Humabs BioMed is now a subsidiary of Vir Biotechnology Vir Biotechnology Builds Pipeline, Capabilities, and Lays Out Strategy to Address Serious Infectious Diseases 21.09.2017 Data on Novel Bi-specific Antibody to Treat Zika Virus Infection Published in "Cell" ...